The higher dose may be considered for patients needing additional glycemic control and weight reduction
Putting numbers in context Practically speaking, a weight loss of 5% over six months is frequently used as a statistical benchmark for drugs and smaller thresholds are used in supplement research
However, the mentioned adverse reactions can be averted through the careful patient monitoring and restricting the duration of hydroquinone therapy (Nordlund et al., 2006b)
Zhang H, Wu X, Liang J, Kirberger M, Chen N
A phase 2 trial (NCT05063539) was initiated in September 2021 for assessing the safety, tolerability, and efficacy of LY3372689 in 330 patients with early symptomatic AD with progressive memory changes for 6 months and who met the criterion of having a positive flortaucipir-PET scan